Phase l/II Study of Ruxolitinib for Acute Leukemia
Clinical trial NCT01251965 · TERMINATED
Trial details
- NCT number
- NCT01251965
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2012-07-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.